This Biotech Clubhouse Session will cover insights into best practices for providing access to medicines in the developing from industry experts exploring learnings from Gilead Science’s HIV and Hepatitis C Access to Medicines Program. We take lessons from past efforts, look at the current COVID response, and discuss a path forward for low and middle-income countries’ access to COVID vaccines, as well as future life-saving medicines.
Guests: Clifford Samuel, Claudio Lilienfeld, Kash Rangan.
Host: Chris Garabedian.
Full auto-generated transcript: click here
Originally aired on June 7th, 2021 on Biotech Clubhouse. Shared with permission
